logo

ACRS

Aclaris Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ACRS fundamentals

Aclaris Therapeutics (ACRS) released its earnings on Aug 7, 2025: revenue was 1.77M (YoY -36.10%), beat estimates; EPS was -0.13 (YoY +13.33%), met estimates.
Revenue / YoY
1.77M
-36.10%
EPS / YoY
-0.13
+13.33%
Report date
Aug 7, 2025
EPS
Revenue

Revenue & Expenses

ACRS has released its 2025 Q3 earnings report, with revenue of 3.30M, reflecting a YoY change of -24.09%, and net profit of -14.61M, showing a YoY change of -92.64%. The Sankey diagram below clearly presents ACRS's revenue sources and cost distribution.

Key Indicators

Aclaris Therapeutics (ACRS) key financial stats and ratios, covering profitability, financial health, and leverage.
Aclaris Therapeutics (ACRS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Aclaris Therapeutics (ACRS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Aclaris Therapeutics (ACRS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Aclaris Therapeutics (ACRS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Aclaris Therapeutics (ACRS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield